Literature DB >> 9229124

Pathology and pathogenesis of demyelinating diseases.

M Storch1, H Lassmann.   

Abstract

Multiple sclerosis is an inflammatory demyelinating disease of the central nervous system of putative autoimmune origin. In the present review the hypothesis that autoimmunity against multiple different brain antigens can lead to T-cell mediated brain inflammation and that multiple different immunological mechanisms may be responsible for the destruction of myelin is highlighted. The multitude of possible pathogenetic mechanisms is reflected in multiple sclerosis patients by a broad spectrum of disease susceptibility genes and by a profound heterogeneity of pathology and immunopathogenesis of the lesions.

Entities:  

Mesh:

Year:  1997        PMID: 9229124     DOI: 10.1097/00019052-199706000-00004

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  5 in total

Review 1.  Early-stage multiple sclerosis : what are the treatment options?

Authors:  Per Soelberg Sorensen
Journal:  Drugs       Date:  2004       Impact factor: 9.546

2.  Axonal damage is T cell mediated and occurs concomitantly with demyelination in mice infected with a neurotropic coronavirus.

Authors:  A A Dandekar; G F Wu; L Pewe; S Perlman
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

3.  Pupillary function in early multiple sclerosis.

Authors:  Jukka Surakka; Juhani Ruutiainen; Anders Romberg; Pauli Puukka; Erkki Kronholm; Hannu Karanko
Journal:  Clin Auton Res       Date:  2008-05-06       Impact factor: 4.435

4.  Differential binding patterns of anti-sulfatide antibodies to glial membranes.

Authors:  Gavin R Meehan; Rhona McGonigal; Madeleine E Cunningham; Yuzhong Wang; Jennifer A Barrie; Susan K Halstead; Dawn Gourlay; Denggao Yao; Hugh J Willison
Journal:  J Neuroimmunol       Date:  2018-07-09       Impact factor: 3.478

5.  miR-20a suppresses Treg differentiation by targeting Map3k9 in experimental autoimmune encephalomyelitis.

Authors:  Yishu Wang; Chong Xie; Yaying Song; Weiwei Xiang; Jing Peng; Lu Han; Jie Ding; Yangtai Guan
Journal:  J Transl Med       Date:  2021-05-26       Impact factor: 5.531

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.